DSP Healthcare Fund - Direct Plan - IDCW

DSP Mutual Fund · Sectoral/Thematic · Direct · IDCW

NAV · as of 10/09/2026

29.40

-0.47%

+7.44%

Key stats

Expense ratio: 0.71%
AUM: ₹3.64 K Cr
Launched: 30/11/2018
Fund manager: Chirag Dagli
Portfolio turnover: 0.20%
Risk: Very High Risk
Min lump-sum: ₹100
Min SIP: ₹100/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

DSP Healthcare Fund - Direct Plan - IDCW

11/08/2026 to 10/09/2026

O - H - L -

1W-1.03%

1M-0.59%

3M+9.08%

6M+23.71%

1Y+7.44%

3Y+11.85%

5Y+5.59%

MAX+192.43%

Top holdings

34 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
8.40%
2.
Ipca Laboratories Ltd
Healthcare
8.15%
3.
Cipla Ltd
Healthcare
8.10%
4.
Sai Life Sciences Ltd
Healthcare
7.07%
5.
Gland Pharma Ltd
Healthcare
6.33%
6.
Treps / Reverse Repo Investments
5.92%
7.
Apollo Hospitals Enterprise Ltd
Healthcare
5.79%
8.
Globus Medical Inc Class A
Healthcare
5.55%
9.
Alkem Laboratories Ltd
Healthcare
4.64%
10.
Cohance Lifesciences Ltd
Healthcare
3.74%
11.
Vijaya Diagnostic Centre Ltd
Healthcare
3.46%
12.
Alembic Pharmaceuticals Ltd
Healthcare
3.16%
13.
Manipal Health Enterprises Ltd
Healthcare
3.01%
14.
Procter & Gamble Health Ltd
Healthcare
2.89%
15.
Kovai Medical Center & Hospital Ltd
Healthcare
2.73%
16.
Pfizer Ltd
Healthcare
2.73%
17.
Divi's Laboratories Ltd
Healthcare
2.33%
18.
Indoco Remedies Ltd
Healthcare
1.96%
19.
Concord Biotech Ltd
Healthcare
1.94%
20.
Intuitive Surgical Inc
Healthcare
1.74%
21.
Unichem Laboratories Ltd
Healthcare
1.59%
22.
Syngene International Ltd
Healthcare
1.33%
23.
Nephrocare Health Services Ltd
Healthcare
1.19%
24.
ICICI Lombard General Insurance Co Ltd
Financial Services
1.08%
25.
Aarti Drugs Ltd
Healthcare
0.99%
26.
Abbott Laboratories
Healthcare
0.88%
27.
Global X Genomics & Biotechnology ETF
0.87%
28.
Eris Lifesciences Ltd Registered Shs
Healthcare
0.84%
29.
Net Receivables/Payables
0.82%
30.
Jupiter Life Line Hospitals Ltd
Healthcare
0.47%
31.
Laxmi Dental Ltd
Healthcare
0.16%
32.
GRAIL Inc
Healthcare
0.16%
33.
Illumina Inc
-
34.
Emcure Pharmaceuticals Ltd
-

Sector allocation

Healthcare91.32%
Unclassified7.60%
Financial Services1.08%

Comparable peers

SBI Healthcare Opportunities IDCW Reinvest Direct Plan
SBI Healthcare Opportunities IDCW Reinvest (DR) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
DSP Healthcare IDCW Reinvest Direct Plan
DSP Healthcare IDCW Reinvest (DR) · ₹3.64 K Cr AUM
1Y+15.26%
3Y+21.48%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-

Investment objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities.

Scheme details

Scheme code: 145455
Fund house: DSP Mutual Fund
Category: Open Ended
Type: Equity Schemes
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: IDCW
ISIN (Growth): INF740KA1LH9
ISIN (Div. Reinvest): INF740KA1LI7
Tradable on exchange: No

Kuvera page